Pain Relief and Antimicrobial Activity in Alveolar Osteitis after Platelet-Rich Fibrin Application—A Non-Randomized Controlled Study
Source abstract
Abstract
The objective was to compare pain relief in alveolar osteitis achieved by the application of platelet-rich fibrin (PRF) and aspirin cones, and to assess the influence of both treatments on bacterial concentrations in post-extraction wounds. A split-mouth, single-center, non-randomized controlled trial was conducted in 30 patients. Pain relief was assessed using the visual analog scale at three time points (before, 24 h after, and 48 h after intervention). Bacterial concentrations were evaluated from cultures of swab samples collected at the three time points. A Wilcoxon matched-pairs signed-rank test was performed to detect differences in distributions of scalar variables between treatment with PRF and aspirin cones. Pain relief at 24 h and 48 h after treatment was significantly higher (p = 0.003) with PRF application than with aspirin cone placement. Additionally, PRF application caused a significantly higher reduction in aerobic bacteria concentration, an average increase, instead of a decrease, in lactic acid bacilli concentration in the first 24 h, and a significantly greater increase in streptococci concentration at 48 h follow-up. PRF provides better pain relief than aspirin cones in alveolar osteitis. Bacterial concentrations in the extraction wounds are consistent with the pain relief achieved after PRF or aspirin application.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Periodontal Regeneration and Treatments · Oral and Maxillofacial Pathology · dental development and anomalies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oral Surgery, Central Clinical Hospital, Medical University of Lodz, Pomorska 251, 92-213 Lodz, Poland
Funding
Medical University of Lodz
References (31)
Show source-provided references
1. Efficacy of different methods used for dry socket management: A systematic review
2. A Study to Evaluate the Efficacy of Honey in the Management of Dry Socket10.4103/ccd.ccd_283_18 ↗
3. Role of turmeric in management of alveolar osteitis (dry socket): A randomised clinical study10.1016/j.jobcr.2017.08.005 ↗
4. Dry Socket Etiology, Diagnosis, and Clinical Treatment Techniques10.5125/jkaoms.2018.44.2.52 ↗
5. Effectiveness of platelet-rich fibrin in the management of pain and delayed wound healing associated with established alveolar osteitis (dry socket)10.4103/ejd.ejd_346_16 ↗
6. Xiang, X., Shi, P., Zhang, P., Shen, J., and Kang, J. (2019). Impact of platelet-rich fibrin on mandibular third molar surgery recovery: A systematic review and meta-analysis. BMC Oral Health, 19.10.1186/s12903-019-0824-3 ↗
7. Alveolar osteitis: A comprehensive review of concepts and controversies10.1155/2010/249073 ↗
8. The Efficacy of Concentrated Growth Factor in the Healing of Alveolar Osteitis: A Clinical Study10.1155/2020/9038629 ↗
9. Comparision between neocone, alvogyl and zinc oxide eugenol packing for the treatment of dry socket: A double blind randomised control trial10.1007/s12663-014-0667-z ↗
10. Versatility of platelet rich fibrin in the management of alveolar osteitis—A clinical and prospective study10.1016/j.jobcr.2017.05.002 ↗
11. Platelet rich fibrin in the management of established dry socket10.5125/jkaoms.2017.43.3.160 ↗
12. A Comparative Clinical Study between Concentrated Growth Factor and Low-Level Laser Therapy in the Management of Dry Socket10.1055/s-0040-1714765 ↗
13. Comparative evaluation of zinc oxide eugenol versus gelatin sponge soaked in plasma rich in growth factor in the treatment of dry socket: An initial study10.4103/0976-237X.111592 ↗
14. Assessment of Healing Using Alvogyl and Platelet Rich Fibrin in Patients with Dry Socket—An Evaluative Study10.4103/ams.ams_259_19 ↗
15. Efficacy of Platelet-Rich Fibrin After Mandibular Third Molar Extraction: A Systematic Review and Meta-Analysis10.1016/j.joms.2017.01.022 ↗
16. The impact of plasma rich in growth factors on clinical and biological factors involved in healing processes after third molar extraction10.1002/jbm.a.32882 ↗
17. Effect of plasma rich in growth factors on alveolar osteitis10.4103/0975-5950.102150 ↗
18. Comparative evaluation of growth factors from platelet concentrates: An in vitro study10.4103/jisp.jisp_678_18 ↗
19. The PDGF family: Four gene products form five dimeric isoforms10.1016/j.cytogfr.2004.03.007 ↗
20. Serafini, G., Lopreiato, M., Lollobrigida, M., Lamazza, L., Mazzucchi, G., Fortunato, L., Mariano, A., D’abusco, A.S., Fontana, M., and De Biase, A. (2020). Platelet Rich Fibrin (PRF) and Its Related Products: Biomolecular Characterization of the Liquid Fibrinogen. J. Clin. Med., 9.10.3390/jcm9041099 ↗
21. TGF-β control of stem cell differentiation genes10.1016/j.febslet.2012.03.023 ↗
22. Molecular and biological properties of the vascular endothelial growth factor family of proteins10.1210/edrv-13-1-18 ↗
23. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part II: Platelet-related biologic features10.1016/j.tripleo.2005.07.009 ↗
24. Postextractive Alveolar Ridge Preservation Using L-PRF: Clinical and Histological Evaluation
25. Antibacterial effect of plasma rich in growth factors (PRGF®-Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains10.1111/j.1365-2230.2011.04303.x ↗
26. Drago, L., Bortolin, M., Vassena, C., Taschieri, S., and Del Fabbro, M. (2013). Antimicrobial activity of pure platelet-rich plasma against microorganisms isolated from oral cavity. BMC Microbiol., 13.10.1186/1471-2180-13-47 ↗
27. Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin10.4103/0970-9290.186231 ↗
28. Antimicrobial activity of sodium citrate against Streptococcus pneumoniae and several oral bacteria10.1111/j.1472-765X.2010.02932.x ↗
29. Comparative Evaluation of Antimicrobial Efficacy of Platelet-rich Plasma, Platelet-rich Fibrin, and Injectable Platelet-rich Fibrin on the Standard Strains of Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans10.4103/ccd.ccd_367_18 ↗
30. Platelet-rich fibrin (PRF): A second-generation platelet concentrate. Part I: Technological concepts and evolution10.1016/j.tripleo.2005.07.008 ↗
31. Therapeutics of stem cells in periodontal regeneration10.4103/0976-9668.82316 ↗